- Staat
- PA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 04.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Disorientation
Influenza like illness
Syncope
Symptomtext
patient fainted and had some symptoms such as flu like symptoms, disoriented the day after the vaccine was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 26.01.2023
- Impfdatum
- 18.01.2023
- Beginn
- 19.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Hypersomnia
Infection
Injection site erythema
Injection site swelling
Symptomtext
Brought in by mom. Seen 8 days ago for 2 year well child visit. Usual vaccines given with Dtap and Flu vaccines given on L thigh. Left clinic in no distress. Mom noticed the next day the area on L thigh where vaccines were given becoming red and swollen, with erythema moving down thigh to lower leg. Brought to urgent care where child diagnosed with infection and placed on Cephalexin which he refused to take. Mom denies any fever and erythema has completely resolved. Mom states child taking excessively long naps in the afternoon since incident. Sleeps at usual nap time of 3pm and will sleep until 11 pm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 30.11.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site warmth
Symptomtext
Red, swollen, warm to touch entire upper left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Benedryl
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 01.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 27,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site swelling
Injection site warmth
Upper respiratory tract infection
Symptomtext
Localized swelling of right thigh in duration warmth 2-3 inches in diameter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- URI on 10/03/2022
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 14.10.2022
- Impfdatum
- 08.10.2022
- Beginn
- 09.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Adverse reaction
Blister
Genital blister
Pain
Pruritus
Pyrexia
Urticaria
Symptomtext
Pt came to pharmacy today to alert pharmacist of an adverse reaction he believes he is having to the shingrix vaccine. Pt had both his second dose of shingrix and the fluzone quad on Saturday 10/08/2022. Pt initially was only going to get the fluzone quad, but the pharmacist saw that the patient was overdue for his second shingrix vaccine, which was recommended. Pt was unsure if he should get it or not at first, being he said he "got sick" after his first dose. When the pharmacist inquired more about his symptoms of "getting sick" after the first dose, the patient stated that he had the body aches, chills and fever after his first dose. Rph discussed this further with the patient and explained that those symtoms can be side effects with most vaccinations, but it does not necessarily mean that he is allergic to the vaccine. It was explained to the patient that this was a normal immune respsonse to a vaccine. Pt agreed that he would get the second dose, which was given on Saturday 10/8/2022. Pt states on Sunday, 10/09/2022 he woke up itching with blisters and hives on his arms, chest/stomach and genital area. He also said his body was achy all over and had a fever to the touch. Rph referred the patient to urgent care as well as contacting his primary doctor. Pt refused though and said he wants to "let the blisters run their course." Rph again persisted that the patient should get checked out by a doctor due to the location and amount of blisters the patient was describing. Pt again stated that he wasn't going to get checked out anywhere today. He did say that he would call his primary doctor on Monday though.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Amlodipine, atorvastatin, folic acid, carvedilol, vitamin B-1
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 26.09.2022
- Impfdatum
- 24.09.2022
- Beginn
- 24.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site swelling
Symptomtext
PATIENT EXPERIENCED MINOR SWELLING IN ARM AT THE SITE OF INJECTION WITHIN 5 MIN OF RECIEVING THE VACCINE. SYMPTOMS HAVE SUBSIDED SINCE THEN
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 18.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 28.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Underdose
Symptomtext
No adverse event; incorrect Moderna covid19 strength vaccine given. Reported to Nurse Practitioner. Directed to re-vaccinate with correct Moderna covid19 vaccine dose. Trying to contact parent, phone number listed is out of service. Mailed a letter to parent to have them call our office to have them come in to re-vaccinate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 16.05.2023
- Impfdatum
- 28.04.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 13,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
Incorrect Moderna covid 19 vaccine strength of vaccine given on April 28, 2023. I called mom over the phone and requested she bring in child to vaccinate with correct dose. Parent brought in child to vaccinate with correct Moderna vial vaccine and dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.11.2022
- Impfdatum
- 22.11.2022
- Beginn
- 22.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
patient was given a flu vaccine on 11/22/22 but had previously received a flu vaccine on 10/18/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 19.10.2022
- Impfdatum
- 06.10.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
maternal vaccine exposure with no reported adverse event; Initial information received on 06-Oct-2022 regarding an unsolicited valid non-serious case from other health professional. This case involves a 25 years old female patient who was exposed to vaccine influenza quadrival A-B vaccine [Fluzone QIV] in context of maternal vaccine exposure with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported maternal vaccine exposure with no reported adverse event occurred at 17 weeks of pregnancy and the patient was exposed to influenza quadrival A-B vaccine at 17 weeks of pregnancy, during second pregnancy trimester for influenza quadrival A-B vaccine. The date of last menstrual period was reported as 10-Jun-2022. The estimated due date is 04-Apr-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient previous pregnancy. On 06-Oct-2022, the patient received a dose 1 of suspect influenza quadrival A-B vaccine suspension for injection at an unknown dose (lot UT7682KA, expiry date: not reported) via intramuscular route in the left deltoid for prophylactic vaccination(immunisation). On 06-Oct-2022 the patient developed a non-serious maternal vaccine exposure with no reported adverse event (exposure during pregnancy, latency: same day). Action taken: Not applicable. Outcome: Unknown. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,6
- Geschlecht
- M
- Eingang
- 11.10.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
The patient received this dose of the Covid vaccine approximately 4 weeks early.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 05.10.2022
- Impfdatum
- 05.10.2022
- Beginn
- 05.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injury associated with device
Symptomtext
I am the reporter of this event. I am a pharmacist and received a needle stick. I was advised by our Market Director to place a VAERS report. The actual person who received the shot is not involved with this report or the event. I intend to have blood work done
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injury associated with device
- Hospital-Tage
- -
- Labordaten
- none as yet
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
patient was pregnant with no reported adverse event; Initial information received on 23-Sep-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves Adult female patient who was exposed to vaccine Influenza Quadrival A-B Vaccine [Fluzone QIV] in context of patient was pregnant with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. Event occurred at unknown gestation period<<the gestation period at onset and gestation period at exposure data needs to be populated, if available>> The date of last menstrual period was reported as 22-Apr-2022. The estimated due date is 23-Jan-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancies. On an unknown date, the patient received 1 dosage form (DF); dose number: 1 of suspect Influenza Quadrival A-B Vaccine Suspension for injection (strength, route, frequency: unknown) (lot number: UT7682KA and expiry date: unknown) via unknown route in the left deltoid for Prophylactic vaccination (Immunisation). Date of last injection was 22-Sep-2022. On an unknown date, the patient developed a non-serious event of, patient was pregnant with no reported adverse event (maternal exposure during pregnancy) (unknown latency). It is unknown if there were lab data/results available. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. At time of reporting, the outcome was Unknown. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 22.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
vaccine exposure during pregnancy with no reported adverse event; Initial information received on 23-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 28 years old female patient who was exposed to vaccine Influenza quadrival A-B vaccine [Fluzone QIV] in context of vaccine exposure during pregnancy with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported vaccine exposure during pregnancy with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date is 26-Feb-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had no previous pregnancy/ies. On 22-Sep-2022, the patient received a dose 1 of suspect Influenza quadrival A-B vaccine, suspension for injection (lot UT7682KA; strength and expiry date not reported) via unknown route in the left deltoid for prophylactic vaccination. On 22-SEP-2022 the patient had vaccine exposure during pregnancy with no reported adverse event (exposure during pregnancy) (latency; on same day). Relevant prenatal testing after exposure was not reported. Action taken : not applicable. At time of reporting, the outcome was Unknown for the event vaccine exposure during pregnancy with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Symptomtext
Pregnant patient received fluzone QV vaccine with no reported adverse event; Initial information received on 14-Sep-2022 regarding an unsolicited valid non-serious case received from health professional. This case involves a 32-year-old female patient who was exposed to vaccine Influenza Quadrival A-B Vaccine [Fluzone QIV] in context of pregnant patient received fluzone qv vaccine with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e., before pregnancy outcome was known. The reported Pregnant patient received fluzone QV vaccine with no reported adverse event occurred at 37 weeks of pregnancy and during pregnancy trimester. The date of last menstrual period was reported as 27-Dec-2021. The estimated due date is 03-Oct-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was unknown if patient had previous pregnancy. On 14-Sep-2022, the pregnant patient received of suspect Fluzone QIV Suspension for injection at dose 1 DF (dosage form) via intramuscular route in the left deltoid (lot: UT7682KA) for prophylactic vaccination with no reported adverse event (exposure during pregnancy) at same day latency. Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event exposure during pregnancy. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
pregnancy with no reported adverse event; Initial information received on 14-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of pregnancy with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported pregnancy with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date is 03-Mar-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On an unknown date, the patient received an unknown dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (strength, formulation was unknown, lot UT7682KA and expiry date: unknown) via intramuscular route in the left deltoid for prophylactic vaccination. On an unknown date the patient developed a non-serious event of pregnancy with no reported adverse event (exposure during pregnancy) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Patient had no adverse event. It was unknown if the company suspect product inappropriately used as per local Marketing authorization. Action taken : not applicable. Outcome: Unknown Additionally, at time of reporting, the pregnancy was still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 23.09.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
Fluzone QIV last injection administered in pregnancy with no reported adverse event; Initial information received on 15-Sep-2022 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 37 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of fluzone qiv last injection administered in pregnancy with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Fluzone QIV last injection administered in pregnancy with no reported adverse event occurred at 33 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 33 weeks of pregnancy, during third pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 26-Jan-2022. The estimated due date is 18-Nov-2022. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. The patient previous pregnancy was not reported. On 14-Sep-2022, the patient received a dose one of suspect INFLUENZA QUADRIVAL A-B VACCINE at an unknown dose (lot UT7682KA, expiry date: not reported) via intramuscular route in unknown administration site for immunisation. On 14-Sep-2022 the patient developed a non-serious fluzone qiv last injection administered in pregnancy with no reported adverse event (maternal exposure during pregnancy) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Relevant prenatal testing after exposure not reported. Action taken: Not applicable. Outcome: Unknown Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Maternal exposure during pregnancy
No adverse event
Symptomtext
maternal exposure during pregnancy with no adverse event; Initial information received on 09-Sep-2022 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 30 years old female patient who was exposed to vaccine QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of maternal exposure during pregnancy with no adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported maternal exposure during pregnancy with no adverse event occurred at 22 weeks of pregnancy and the patient was exposed to QUADRIVAL A-B VACCINE at 22 weeks of pregnancy, during second pregnancy trimester for QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 08-Apr-2022. The estimated due date is 22-Jan-2023. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. The patient previous pregnancy was not reported. On 08-Sep-2022, the patient received a dose 1 of suspect QUADRIVAL A-B VACCINE suspension for injection at an unknown dose (lot UT7682KA, expiry date: not reported) via intramuscular route in unknown administration site for immunisation. On 08-Sep-2022 the patient had maternal exposure during pregnancy with no adverse event (exposure during pregnancy) same day latency following the administration of QUADRIVAL A-B VACCINE. Relevant prenatal testing after exposure was not reported. Action taken: Not applicable. Outcome: Unknown for the event maternal exposure during pregnancy with no adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Maternal exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
Patient administered Fluzone QIV with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received via health professional. This case involves a 26-year-old female patient who was exposed to vaccine Influenza Quadrival A-B Vaccine [Fluzone Quadrivalent] in context of patient administered fluzone qiv with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known at 22 weeks, during second pregnancy trimester. The date of last menstrual period was reported as 12-Apr-2022. The estimated due date is 17-Jan-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Sep-2022, the regnant patient received suspect Fluzone Quadrivalent vaccine at unknown dose (lot UT7682KA) via intramuscular route in unknown administration site for prophylactic vaccination with no reported adverse event (exposure during pregnancy) same day latency. Action taken: Not applicable. At time of reporting, the outcome was Unknown for the event patient administered fluzone qiv with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
Fluzone QIV administered during pregnancy no adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 23 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of fluzone qiv administered during pregnancy no adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Fluzone QIV administered during pregnancy no adverse event occurred at 13 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 13 weeks of pregnancy, during first pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 14-Jun-2022. The estimated due date is 21-Mar-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Sep-2022, the patient received a dose 1 of suspect INFLUENZA QUADRIVAL A-B VACCINE Suspension for injection (lot UT7682KA) via intramuscular route in the left deltoid for prophylactic vaccination. On 07-SEP-2022 the patient developed a non-serious event fluzone qiv administered during pregnancy no adverse event (exposure during pregnancy) (latency same day)following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event (exposure during pregnancy). At time of reporting, the outcome was Unknown for the event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- F
- Eingang
- 17.09.2022
- Impfdatum
- 09.07.2022
- Beginn
- 09.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
Taking vaccine during pregnancy, with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 31 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of taking vaccine during pregnancy, with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Taking vaccine during pregnancy, with no reported adverse event occurred at 5 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 5 weeks of pregnancy, during first pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 16-Jun-2022. The estimated due date is 23-Mar-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 09-Jul-2022, the patient received an unknown dose of suspect INFLUENZA QUADRIVAL A-B VACCINE Suspension for injection (strength was unknown, lot UT7682KA and expiry date was unknown) via intramuscular route in the deltoid nos for Prophylactic vaccination. On 09-Jul-2022 the patient developed a non-serious event of taking vaccine during pregnancy, with no reported adverse event (maternal exposure timing unspecified) (Latency: same day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken :not applicable. Outcome: Unknown Additionally, at time of reporting, the pregnancy was still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
Vaccine exposure during pregnancy with no reported adverse event; Initial information received on 02-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 30 years old female patient who was exposed to vaccine influenza quadrival A-B vaccine [Fluzone QIV] in context of vaccine exposure during pregnancy with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Vaccine exposure during pregnancy with no reported adverse event occurred at 15 weeks of pregnancy and the patient was exposed to influenza quadrival A-B vaccine at 15 weeks of pregnancy, during second pregnancy trimester for influenza quadrival A-B vaccine. The date of last menstrual period was reported as 14-May-2022. The estimated due date is 19-Feb-2023. The patient has Twin pregnancy. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 31-Aug-2022, the patient received a dose of suspect influenza quadrival A-B vaccine Suspension for injection (strength and dose not reported; lot uT7682KA, expiry date: 30-Jun-2023) via intramuscular route in unknown administration site for prophylactic vaccination. On 31-Aug-2022, (latency: same day) the patient had vaccine exposure during pregnancy with no reported adverse event (exposure during pregnancy) following the administration of influenza quadrival A-B vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Twin pregnancy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 31.08.2022
- Beginn
- 31.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Delivery
Exposure during pregnancy
No adverse event
Symptomtext
Vaccine fluzone QV given in pregnancy with no reported adverse event; Initial information received on 02-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves Adult female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of vaccine fluzone qv given in pregnancy with no reported adverse event. Data regarding this pregnancy were received retrospectively, i.e. after pregnancy outcome was known. The reported Vaccine fluzone QV given in pregnancy with no reported adverse event occurred at 7 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 7 weeks of pregnancy, during first pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 26-Jul-2022. The estimated due date is 02-May-2023. The actual date of delivery is 30-Apr-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 31-Aug-2022, the patient received a 1 unknown dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (strength, formulation was unknown, lot uT7682KA and expiry date: 30-Jun-2023) via intramuscular route in the right deltoid for prophylactic vaccination. On 31-Aug-2022 the patient developed a non-serious event of vaccine fluzone qv given in pregnancy with no reported adverse event (exposure during pregnancy) (latency: same day) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken : not applicable. Outcome: Unknown. Additionally, at time of reporting, the patient delivered a baby at unknown weeks of gestation on 30-Apr-22. Outcome of the pregnancy was reported as unknown and fetal outcome was reported as unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Delivery
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 01.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Symptomtext
vaccine exposure during pregnancy; Initial information received on 02-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 34 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] in context of vaccine exposure during pregnancy. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported vaccine exposure during pregnancy occurred at 16 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 16 weeks of pregnancy, during second pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE. The date of last menstrual period was reported as 20-May-2022. The estimated due date is 23-Feb-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Sep-2022, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE Suspension for injection (lot uT7682KA) via intramuscular route in the left deltoid for prophylactic vaccination. On 01-SEP-2022 the patient reported a non-serious event vaccine exposure during pregnancy (exposure during pregnancy) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event exposure during pregnancy. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 09.09.2022
- Impfdatum
- 08.09.2022
- Beginn
- 09.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
Moderna bivalent vaccine was given too early due to cdc guidelines. Her most recent Moderna booster given 7/31/22, and bivalent booster given 9/8/2022, a few weeks before the two month interval. Patient was not experiencing any adverse effects or side effects after administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -